<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8642">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00818116</url>
  </required_header>
  <id_info>
    <org_study_id>CH-08-001</org_study_id>
    <nct_id>NCT00818116</nct_id>
  </id_info>
  <brief_title>Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL</brief_title>
  <official_title>Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric Intraocular Lens (IOL): Postmarket Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate postoperative visual function in patients
      implanted bilaterally with the ReSTOR Aspheric Intraocular Lens (IOL).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Uncorrected and Best Corrected Visual Acuities (Near and Distance)</measure>
    <time_frame>6 Months Following Cataract Surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measurement of uncorrected (without spectacles or other visual corrective devices) and best-corrected (with spectacles or other visual corrective devices)visual acuity at both near and distance. Visual Acuity (VA) is measured in logMAR. LogMAR is the &quot;logarithm of the minimum angle of resolution&quot;. A lower logMAR value indicates better visual acuity.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Cataracts</condition>
  <arm_group>
    <arm_group_label>ReSTOR Aspheric IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral implantation with the AcrySof ReSTOR Aspheric Intraocular Lens (IOL)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcrySof ReSTOR Aspheric IOL</intervention_name>
    <description>Bilateral implantation with the AcrySof ReSTOR Aspheric Intraocular Lens (IOL) for the replacement of cataract in the natural lens of the eye.</description>
    <arm_group_label>ReSTOR Aspheric IOL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral cataract patients who require natural crystalline lens removal and
             bilateral Intraocular Lens (IOL) implantation.

          -  50~75 years of age

          -  &lt;1 Diopter of astigmatism preoperatively (before surgery) as measured by Keratometry
             readings.

        Exclusion Criteria:

          -  Patients with pre-existing conditions that could skew the results.

          -  Any of conditions before and during surgery specified in the product information.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <lastchanged_date>June 30, 2010</lastchanged_date>
  <firstreceived_date>January 6, 2009</firstreceived_date>
  <firstreceived_results_date>June 30, 2010</firstreceived_results_date>
  <responsible_party>
    <name_title>China: Ethics Committee</name_title>
    <organization>Alcon China</organization>
  </responsible_party>
  <keyword>Cataract</keyword>
  <keyword>visual acuity</keyword>
  <keyword>AcrySof ReSTOR Aspheric Intraoculare Lens</keyword>
  <keyword>Bilateral cataract</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>34 eligible patients were enrolled into the study</recruitment_details>
      <pre_assignment_details>Open-label, single arm, non-randomized</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ReSTOR Aspheric</title>
          <description>Implantation with the AcrySof ReSTOR Aspheric Intraocular Lens (IOL)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ReSTOR Aspheric</title>
          <description>Implantation with the AcrySof ReSTOR Aspheric Intraocular Lens (IOL)</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="34"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="24"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Uncorrected and Best Corrected Visual Acuities (Near and Distance)</title>
        <description>Measurement of uncorrected (without spectacles or other visual corrective devices) and best-corrected (with spectacles or other visual corrective devices)visual acuity at both near and distance. Visual Acuity (VA) is measured in logMAR. LogMAR is the “logarithm of the minimum angle of resolution”. A lower logMAR value indicates better visual acuity.</description>
        <time_frame>6 Months Following Cataract Surgery</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>ReSTOR Aspheric</title>
            <description>Implantation with the AcrySof ReSTOR Aspheric Intraocular Lens (IOL)</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="34"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Uncorrected and Best Corrected Visual Acuities (Near and Distance)</title>
            <description>Measurement of uncorrected (without spectacles or other visual corrective devices) and best-corrected (with spectacles or other visual corrective devices)visual acuity at both near and distance. Visual Acuity (VA) is measured in logMAR. LogMAR is the “logarithm of the minimum angle of resolution”. A lower logMAR value indicates better visual acuity.</description>
            <units>logMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Near Uncorrected Visual Acuity</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.02" spread="0.08"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Near Best-Corrected Visual Acuity</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.01" spread="0.07"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Distance Uncorrected Visual Acuity</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.00" spread="0.07"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Distance Best-Corrected Visual Acuity</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-0.03" spread="0.07"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 Day, 1 Month, 3 Months, and 6 Months following cataract surgery.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ReSTOR Aspheric</title>
          <description>Implantation with the AcrySof ReSTOR Aspheric Intraocular Lens (IOL)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Glare</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alcon Clinical</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>888.451.3937; 817.568.6725</phone>
      <email>medinfo@alconlabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
